Clinical use of MRI: Whole body MR Angiography: normal, pathologic and pitfalls

In the last few years the use of Magnetic Resonance Imaging has shown a proceeding development regarding detection and quantification of pathologies. MRI has been a leading tool for the diagnosis of all organs of the human body including the hollow organs. This review article describes one of the underlying techniques of MRI namely whole body MR angiography concerning indications, data acquisition, the intravenously applied paramagnetic contrast agent, as well as results and limitations. In addition, new techniques to improve diagnostic accuracy are discussed.

[1]  B. Jenkins,et al.  Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. , 1997, Investigative radiology.

[2]  J. Debatin,et al.  [Whole-body MRA on a rolling table platform (AngioSURF)]. , 2000, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[3]  J. Debatin,et al.  Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography. , 2000, AJR. American journal of roentgenology.

[4]  J. Debatin,et al.  0.5 M Gd chelate (Magnevist®) versus 1.0 M Gd chelate (Gadovist®): Dose‐independent effect on image quality of pelvic three‐dimensional MR‐angiography , 2001, Journal of magnetic resonance imaging : JMRI.

[5]  J. Debatin,et al.  Rapid magnetic resonance angiography for detection of atherosclerosis , 2001, The Lancet.

[6]  A. Duerinckx,et al.  Lower extremity MR angiography: universal retrofitting of high-field-strength systems with stepping kinematic imaging platforms initial experience. , 2002, Radiology.

[7]  Stephen J Riederer,et al.  Continuously moving table data acquisition method for long FOV contrast‐enhanced MRA and whole‐body MRI , 2002, Magnetic resonance in medicine.

[8]  J. Debatin,et al.  Optimization of Contrast Dosage for Gadobenate Dimeglumine-Enhanced High-Resolution Whole-Body 3D Magnetic Resonance Angiography , 2002, Investigative radiology.

[9]  J. Debatin,et al.  Detection of atherosclerosis: systemic imaging for systemic disease with whole-body three-dimensional MR angiography--initial experience. , 2003, Radiology.

[10]  J. Hennig,et al.  Background suppression using magnetization preparation for contrast-enhanced 3D MR angiography of the pelvic and lower leg arteries. , 2003, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[11]  M. Reiser,et al.  Moving-table MR angiography of the peripheral runoff vessels: comparison of body coil and dedicated phased array coil systems. , 2003, AJR. American journal of roentgenology.

[12]  J. V. van Engelshoven,et al.  Use of a three‐station phased array coil to improve peripheral contrast‐enhanced magnetic resonance angiography , 2004, Journal of magnetic resonance imaging : JMRI.

[13]  Walter F Block,et al.  Floating table isotropic projection (FLIPR) acquisition: A time‐resolved 3D method for extended field‐of‐view MRI during continuous table motion , 2004, Magnetic resonance in medicine.

[14]  J. Debatin,et al.  MR angiography with venous compression. , 2004, Radiology.

[15]  Bernard Y Ho,et al.  Decreased venous contamination on 3D gadolinium-enhanced bolus chase peripheral mr angiography using thigh compression. , 2004, AJR. American journal of roentgenology.

[16]  J. Debatin,et al.  Peripheral vasculature: whole-body MR angiography with midfemoral venous compression--initial experience. , 2004, Radiology.

[17]  J. Debatin,et al.  Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease. , 2004, AJR. American journal of roentgenology.

[18]  S. Schoenberg,et al.  Cardiovascular screening with parallel imaging techniques and a whole-body MR imager. , 2005, Radiology.

[19]  Michael O Zenge,et al.  High‐resolution continuously acquired peripheral MR angiography featuring partial parallel imaging GRAPPA , 2006, Magnetic resonance in medicine.

[20]  J. Weinreb,et al.  Gadolinium‐based contrast agents and nephrogenic systemic fibrosis: Why did it happen and what have we learned? , 2009, Journal of magnetic resonance imaging : JMRI.

[21]  T. Schroeder,et al.  Whole-body MR angiography with body coil acquisition at 3 T in patients with peripheral arterial disease using the contrast agent gadofosveset trisodium. , 2009, Academic radiology.